...
首页> 外文期刊>Pediatric blood & cancer >Rothia mucilaginosa Rothia mucilaginosa bacteremia: A 10‐year experience of a pediatric tertiary care cancer center
【24h】

Rothia mucilaginosa Rothia mucilaginosa bacteremia: A 10‐year experience of a pediatric tertiary care cancer center

机译:Rishia Mucilaginosa rothia Mucilaginosa菌血症:10年的儿科第三级护理癌症中心经验

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Rothia mucilaginosa is part of the oral and upper respiratory tract flora. Usually, this gram‐positive coccus is not pathogenic; however, in the setting of immunosuppressed hosts, it can cause life‐threatening infections as an opportunistic pathogen. Among a cohort of 1511 hematologic‐oncologic patients at a pediatric tertiary care cancer center, we identified five cancer patients (0.35%) within a period of 10 years having a proven Rothia mucilaginosa bacteremia (1 culture positive: n ?=?3/5;??1 culture positive: n ?=?2/5). With prompt and adequate antibiotic treatment, infection resolved rapidly before recovery of neutrophils and without any sequelae, suggesting that Rothia mucilaginosa bacteremia without organ involvement is not exceptionally problematic in pediatric cancer patients.
机译:摘要羊毛菌属是口腔和上呼吸道植物的一部分。 通常,这种革兰氏阳性的Coccus不是致病; 然而,在免疫抑制宿主的设置中,它可以导致威胁危及生命的感染作为机会主义病原体。 在儿科第三节护理癌症中心的1511名血液学肿瘤患者中,我们在10年内确定了五个癌症患者(0.35%),其验证的RITHIA粘糊精菌血症(1培养阳性:N?3/5 ;?&?1培养阳性:n?= 2/5)。 随着促进和足够的抗生素治疗,感染在嗜中性粒细胞恢复之前迅速解决,没有任何后遗症,表明没有器官受累的Rothia粘菌菌菌菌在儿科癌症患者中并不出乎外有问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号